Cost Variation Study of Various Brands of Anti-Asthmatic Drugs Available in India
Journal Title: Journal of Medical Science And clinical Research - Year 2017, Vol 5, Issue 12
Abstract
Objective: Asthma is chronic inflammatory disorder of lungs that affects people of all ages and is a significant source of morbidity and mortality worldwide. It requires continuous medical care. Higher and unaffordable drug prices are among the major reasons for non-compliance and resultant treatment failure. The cost of drugs plays a major role in patient’s care especially in developing countries. It has been observed that there is a gross variation in the cost of different brands of same generic drug. If doctors are not aware, then they may prescribe costly brands, which ultimately lead to non-adherence. The present study was planned to get some idea about cost differences in various brands of anti-asthmatic drugs. Methods: The minimum and the maximum cost in Rupees (INR) of a particular anti-asthmatic agent manufactured by various pharmaceutical companies in the same strength were noted from latest issue of Drug today 2017. The cost ratio and percentage cost variation were noted for each brand. Results: This study showed a noticeable variation in the prices of anti-asthmatic drugs. The highest percent cost variation was found for Doxophylline400mg(3100%), followed Deflazacort 6mg(1300%), Methylprednisolone 4mg (1104%), Combination of Formoterol and Budesonide (444%), Salbutamol 4mg caps(363%), Theophylline and Salbutamol combination(236%), Ketotifen 1mg(217%).The lowest percent cost variations found were: Fluticasone 50mcg(0.4%), Cromolyn 20mg(2%), Formoterol12mcg(11.5%), Tiotropium 18 mcg(11.5%), Ipratropium 20mcg/200mdi(19%) etc. Conclusion: Government should look into the pricing control policy of anti-asthmatic drugs manufactured by various companies in India, so that pricing of various brands remains uniform, quality assured and affordable. Doctors must prescribe rationally, choosing cost effective medicines based on country`s health situation.
Authors and Affiliations
Jyoti B. Gadhade
Keywords
Related Articles
- EP ID EP521313
- DOI -
- Views 112
- Downloads 0
Neonatal Septicemia: Bacterial Isolates & Their Antibiotics Susceptibility Patterns: A Hospital Based Study
In neonates, sepsis incidence is increasing in the recent years. Neonatal septicemia is an important cause of morbidity & mortality among neonates in India, with an estimated incidence of approximately 4% in intramural l...
Comparison of two Different Doses of Dexmedetomidine as an Adjuvant to Ropivacaine in Caudal Block for Infraumblical Surgery in Paediatric Patients
Introduction: Caudal block is widely used in children for analgesia. Adequate intra and post operative analgesia will not only modify the stress response but also has been shown to reduce morbidity and mortality. Hence,...
Neonatal Ascites– Experience from a Tertiary Care Centre
Objective: Neonatal ascites is rare but difficult problem for Neonatologist. To evaluate clinical investigational profile of Neonatal ascites this study was conducted in a city of northern India. Methods: The Neonates wh...
Evaluation of Sperm DNA Fragmentation Index (DFI) for the Outcome of Assisted Reproductive Technique in Infertile Male
Background: The objective of this study was to determine whether there is any possible relationship between DFI with Assisted Reproductive Technique outcome and also with age and semen parameters. Methods: This was a cas...
Anti Rabies Vaccination compliance: A longitudinal study amongst patients attending Anti Rabies Vaccination OPD in a tertiary care hospital
Background: Rabies is a 100% fatal disease affecting all mammals. Dog is the main reservoir and is a major socioeconomic and public health problem. About 59,000 people die annually due to this disease. It affects all and...